Healthcare / Pharmaceutical RetailersUpdated 2026-05-10 22:07 UTC

HKG/1345 stock hub

HKG/1345 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

HKG/1345is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

2.6B

Hong Kong Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

HKG/1345

In the news

Latest news · HKG/1345

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 11.7P50 18.9P75 41.4

Trailing P/E20.4

P25 10.7P50 17.9P75 38.5

ROE9.7

P25 -14.7P50 2P75 9.4

ROIC10

P25 -10.4P50 1.9P75 10.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All HKG/1345 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

233

Groups with data

Currency

CNY

Showing 233 of 233 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Cayman Islands
Country code	HK
Employees	364
Employees Change	29%
Employees Change Percent	8.66
Enterprise value	HKD 2.6B
Exchange	Hong Kong Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Pharmaceutical Retailers
Isin	KYG2162L1068
Last refreshed	2026-05-10
Market cap	HKD 2.6B
Price	HKD 2.25
Price currency	HKD
Rev Per Employee	3,923,649.71x
Sector	Healthcare
Sic	5122
Symbol	hkg/1345
Website	https://www.pioneer-pharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	4.88%
EV Earnings	20.04x
EV/EBIT	16.32x
EV/EBITDA	13.19x
EV/FCF	12.59x
EV/Sales	1.79x
FCF yield	7.77%
P/B ratio	2.24x
P/E ratio	20.37x
P/S ratio	1.83x
PE Ratio10 Y	14.9x
PE Ratio3 Y	18.95x
PE Ratio5 Y	16.99x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	10.94%
EBITDA Margin	13.43%
FCF margin	14.19%
Gross margin	48.86%
Gross Profit	HKD 697.9M
Gross Profit Growth	-1.35%
Gross Profit Growth Q	-2.58%
Gross Profit Growth3 Y	-3.7%
Gross Profit Growth5 Y	-3.27%
Net Income	HKD 127.3M
Net Income Growth	-24.56%
Net Income Growth Q	17.62%
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Net Income Growth3 Y	-10%
Net Income Growth5 Y	-9.66%
Pretax Margin	11.55%
Profit Margin	8.91%
Profit Per Employee	HKD 349,688
Profitable Years	16
ROA	5.96
Roa5y	7.53
ROCE	11.84
ROE	9.73
Roe5y	14.91
ROIC	9.97
Roic5y	16.65

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	8.81%
Cagr1y	9.34%
Cagr3y	-0.07%
Cagr5y	23.54%
Div CAGR10	-0.49%
Div CAGR3	27.01%
Div CAGR5	5.1%
EPS Growth	-23.8
EPS Growth Q	19.29
EPS Growth Quarters	1
EPS Growth Years	0
EPS Growth3 Y	-8
EPS Growth5 Y	-9.18
FCF Growth	13.91%
FCF Growth Q	81.83%
FCF Growth3 Y	22.12%
OCF Growth	-2.56%
OCF Growth Q	13.54%
OCF Growth10 Y	10.92%
OCF Growth3 Y	19.19%
Revenue Growth	-16.17x
Revenue Growth Q	-10.79x
Revenue Growth Years	0x
Revenue Growth3 Y	-7.99x
Revenue Growth5 Y	-4.71x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	HKD 0.87
Assets	HKD 1.7B
Cash	HKD 187.6M
Current Assets	HKD 1.1B
Current Liabilities	HKD 349.1M
Debt	HKD 135.1M
Debt EBITDA	HKD 0.7
Debt Equity	HKD 0.12
Debt FCF	HKD 0.67
Equity	HKD 1.2B
Interest Coverage	57.32
Liabilities	HKD 494.4M
Long Term Assets	HKD 533.7M
Long Term Liabilities	HKD 145.3M
Net Cash	HKD 52.5M
Net Cash By Market Cap	HKD 2.01
Net Cash Growth	-5.13%
Net Debt EBITDA	HKD -0.27
Net Debt Equity	HKD -0.05
Net Debt FCF	HKD -0.26
Tangible Book Value	HKD 1.1B
Tangible Book Value Per Share	HKD 0.99
WACC	3.13

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.22
Inventory Turnover	2.12
Net Working Capital	HKD 626.7M
Quick ratio	1.81
Working Capital	HKD 748.7M
Working Capital Turnover	HKD 2.15

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.99%
Dividend Growth	0%
Dividend Growth Years	1%
Dividend per share	HKD 0.12
Dividend Years	6
Dividend Yield	5.47%
Ex Div Date	2026-06-03
Last Dividend	HKD 0.06
Payout Ratio	111.44%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	132.59%
1Y total return	9.34%
200-day SMA	2.15
3Y total return	-0.21%
50-day SMA	2.28
50-day SMA vs 200-day SMA	50over200
5Y total return	187.66%
All Time High	7.79
All Time High Change	-71.12%
All Time High Date	2014-11-14
All Time Low	0.38
All Time Low Change	490.24%
All Time Low Date	2019-11-25
ATR	0.04
Beta	-0.19
Beta1y	0.15
Beta2y	0
Ch YTD	-4.66
High	2.25
High52	2.4
High52 Date	2026-01-06
High52ch	-6.25%
Low	2.14
Low52	1.59
Low52 Date	2025-08-20
Low52ch	41.51%
Ma50ch	-1.14%
Price vs 200-day SMA	4.51%
RSI	48.85
RSI Monthly	53.65
RSI Weekly	52.06
Sharpe ratio	0.23x
Sortino ratio	0.5
Total Return	6.46%
Tr YTD	-4.66
Tr1m	1.81%
Tr1w	-0.44%
Tr3m	-3.43%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	HKD 156.3M
Operating Income Growth	-14.67
Operating Income Growth Q	-25.01
Operating Income Growth3 Y	-7.75
Operating Income Growth5 Y	-4.47
Operating margin	10.94

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	215,972,000%
Shares Insiders	0.96%
Shares Institutions	0.46%
Shares Out	1,158,964,000
Shares Qo Q	-2.03%
Shares Yo Y	-0.99%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	HKD 202.6M
Average Volume	25,600x
Bv Per Share	1.01
CAPEX	HKD -30.3M
Ch10y	30.06
Ch1m	1.81
Ch1w	-0.44
Ch1y	2.74
Ch3m	-3.43
Ch3y	-12.11
Ch5y	118.4
Ch6m	10.84
Change	6.13%
Change From Open	3.21
Close	2.12
Days Gap	2.83
Depreciation Amortization	36,792,439.5
Dollar Volume	166,500
Earnings Date	2026-05-29
EBIT	HKD 156.3M
EBITDA	HKD 191.8M
EPS	HKD 0.11
F Score	6
FCF	HKD 202.6M
FCF EV Yield	7.94x
FCF Per Share	HKD 0.17
Financing CF	-69,956,816
Fiscal Year End	December
Founded	1,996
Graham Number	1.58227
Graham Upside	-29.68
Income Tax	HKD 48.1M
Investing CF	-92,846,210
Is Primary Listing	1
Last Earnings Date	2026-03-30
Last Report Date	2025-12-31
Lynch Fair Value	HKD 0.55
Lynch Upside	-75.46
Ma150	2.19
Ma150ch	2.88%
Ma20	2.26
Ma20ch	-0.53%
Net CF	70,143,768
Next Earnings Date	2026-05-29
Open	2.18
P FCF Ratio	12.87
P OCF Ratio	11.19
Payment Date	2025-10-20
Position In Range	100
Ppne	212,871,036.3
Price Date	2026-05-06
Price EBITDA	HKD 13.59
Ptbv Ratio	2.27
Relative Volume	2.89x
Revenue	1,428,208,493x
Tax By Revenue	3.37x
Tax Rate	29.13%
Tr6m	10.84%
Volume	74,000
Z Score	5.47

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

HKG/1345 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+5.5%

$0.12 annual per share

Payout ratio

+111.4%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+5.1%

1 consecutive years of growth

Total shareholder yield

+6.5%

Next ex-dividend date: 2026-06-03

Performance

HKG/1345 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns HKG/1345?

Insider, institutional, and short-interest positioning.

Institutional ownership

+0.5%

Share of float held by funds and institutions

Insider ownership

+1.0%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-1.0%

Negative means the company is buying back shares.

Technical

HKG/1345 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

48.8

Neutral momentum band

Price vs 200-day MA

+4.5%

50/200-day relationship not available

Beta (5Y)

-0.19

Less volatile than the market

Sharpe ratio

0.23

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About HKG/1345

Hub-level FAQ points readers to the deeper analysis pages.

What is the current hkg/1345 stock rating?

hkg/1345 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full hkg/1345 analysis?

The full report lives at /stocks/hkg/1345/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for hkg/1345?

The latest report frames hkg/1345 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the hkg/1345 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.